James Hambro & Partners’s Pfizer PFE Stock Holding History

James Hambro & Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-28,700	Closed	-$1.05M	–	58
2023 Q2	$1.05M	Hold	28,700	–	–	0.07%	31
2023 Q1	$1.17M	Hold	28,700	–	–	0.09%	32
2022 Q4	$1.47M	Hold	28,700	–	–	0.11%	29
2022 Q3	$1.26M	Hold	28,700	–	–	0.11%	31
2022 Q2	$1.51M	Hold	28,700	–	–	0.13%	29
2022 Q1	$1.49M	Hold	28,700	–	–	0.11%	31
2021 Q4	$1.7M	Hold	28,700	–	–	0.12%	31
2021 Q3	$1.23M	Hold	28,700	–	–	0.09%	35
2021 Q2	$1.12M	Hold	28,700	–	–	0.09%	34
2021 Q1	$1.04M	Sell	28,700 -2,287	-7%	-$81.2K	0.1%	37
2020 Q4	$1.14M	Buy	30,987 +737	+2%	+$27K	0.13%	30
2020 Q3	$1.05M	Hold	30,250	–	–	0.15%	29
2020 Q2	$938K	Sell	30,250 -3,647	-11%	-$124K	0.15%	30
2020 Q1	$1.05M	Hold	33,897	–	–	0.21%	27
2019 Q4	$1.26M	Sell	33,897 -96,583	-74%	-$3.44M	0.21%	27
2019 Q3	$4.45M	Buy	+130,480	New	+$4.74M	0.89%	20
2019 Q1	$10.5M	Buy	260,431 +246,350	+1,750%	+$9.87M	3.07%	11
2018 Q4	$583K	Hold	14,081	–	–	0.23%	26
2018 Q3	$589K	Sell	14,081 -1,181	-8%	-$45.5K	0.2%	21
2018 Q2	$526K	Sell	15,262 -4,785	-24%	-$164K	0.19%	21
2018 Q1	$675K	Hold	20,047	–	–	0.27%	23
2017 Q4	$690K	Buy	+20,047	New	+$684K	0.38%	20

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

James Hambro & Partners's PFE Position: Q3 2023 in Review

James Hambro & Partners sold out of Pfizer (PFE) in Q3 2023, closing a stake of 28,700 shares — an estimated $1.05M sold.

James Hambro & Partners first reported a position in PFE in Q4 2017 and held it in 22 quarters. The position peaked at $10.5M in Q1 2019. 2,926 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

James Hambro & Partners reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
James Hambro & Partners sold 28,700 Pfizer shares in Q3 2023, an estimated $1.05M.
James Hambro & Partners first reported a position in Pfizer in Q4 2017 and held it in 22 quarters.
James Hambro & Partners's Pfizer position peaked at $10.5M in Q1 2019.
2,926 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on James Hambro & Partners's 13F filing for Q3 2023, filed 24 Oct 2023.